17 alpha-hydroxyprogesterone caproate has been researched along with Vascular Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arai, F; Chekir, C; Emi, Y; Hiramatsu, Y; Kamada, Y; Kikuchi, Y; Matsuda, M; Nakatsuka, M; Sasaki, A; Shimizu, K; Tabuchi, K | 1 |
1 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Vascular Diseases
Article | Year |
---|---|
Altered arterial stiffness in male-to-female transsexuals undergoing hormonal treatment.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Administration, Oral; Adult; Cross-Sectional Studies; Drug Implants; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hydroxyprogesterones; Japan; Male; Medroxyprogesterone; Middle Aged; Progestins; Transsexualism; Vascular Diseases; Vascular Stiffness | 2012 |